Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD

Chest

Volumn 121, Issue 3 SUPPL., 2002, Pages 702-707

  Wolkove, Norman ^a   Kamel, Hany ^a   Rotaple, Michael ^a   Baltzan Jr , Marc A ^a  

^a Research Department   (Canada)

Author keywords

Bronchodilators; Ipratropium; Mucus clearance device; Obstructive lung disease; Physiotherapy; Salbutamol

Indexed keywords

BRONCHODILATING AGENT; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METERED DOSE INHALER; OXYGEN SATURATION; PRIORITY JOURNAL; SPIROMETRY; WALKING;

EID: 0036207571     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.3.702     Document Type: Article

References (19)

1. Interpretation of bronchodilator response in patients with obstructive airways disease
2. The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD
3. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone
4. 2 agonists in patients with chronic obstructive pulmonary disease
5. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis
6. A comparison of flutter valve with percussion in stable cystic fibrosis (CF) patients
7. The efficacy and safety of the Flutter VRP1 for the treatment of bronchiectasis
8. The flutter VRP1: A new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma
9. Reference spirometric values using techniques and equipment that meets ATS recommendations
10. Anticholinergic, antimuscarinic bronchodilators
11. Choice of bronchodilator therapy in chronic obstructive pulmonary disease
12. Clinical aspects of inhaled anticholinergic therapy
13. Dose response study of ipratropium bromide aerosol on maximal performance in stable patients with chronic obstructive pulmonary disease
14. Drug treatment of COPD: Controversies about agents and how to deliver them
15. Evaluation of VRP1 physiotherapy
16. Clinical evaluation of oscillating positive expiratory pressure for enhancing expectoration in diseases other than cystic fibrosis
17. Physiotherapy with the VRP1 for chronic obstructive pulmonary disease: Results of a multi center comparative study
18. Oscillating breathing as chest physiotherapy in patients with chronic obstructive pulmonary disease
19. Clinical evaluation of a new device for home chest physiotherapy in non-hypersecretive COPD patients